Together we will beat cancer

Donate

Cervical cancer is more common in younger women, with around 3,200 people diagnosed in the UK each year. It develops in the lining of the cervix – the lower part of the womb – and the main symptom is unusual or unexplained vaginal bleeding.

First immunotherapy approved for cervical cancer in England and Scotland

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It’s now an approved treatment for them in England and Scotland.

Read More

Our nurses answer your frequently asked questions about cancer

Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.

Read More

Into the archives: the story of HPV and cervical cancer

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

Read More

How our global activity is tackling cancer prevention in low- and middle-income countries

This entry is part 1 of 3 in the series CRUK Global

Focusing on cancer prevention globally is essential; we cannot say we have beaten cancer until we have beaten it everywhere.

Read More

New study supports extending cervical screening intervals for people who test negative for HPV

A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening

Read More

New insights on self-sampling for cervical cancer screening

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

Read More

Cervical screening in Wales extended to every 5 years: Why the switch?

Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.

Read More

The vaccination of a generation? – That Cancer Conversation

This entry is part 4 of 8 in the series That Cancer Conversation

Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India ‘eliminate’ cervical cancer.

Read More

“That is what I dream”: India’s journey to rolling out the HPV vaccine

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

Read More

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.

Read More